亚胺培南西司他丁钠与莫西沙星治疗重症社区获得性肺炎的疗效及经
CHINA HEALTH STANDARD MANAGEMENT, Vol.8, No.18
74
合理用药标准前研究 ●
临床研究
意义。钝针穿刺扣眼形成期间非专人穿刺的方法不仅减轻了血液透析护理的人力资源压力，还让患者参与到自身管理中，不断促进护患关系的持续和谐发展。但因对比观察时间尚短，远期对动静脉内瘘流量的影响、动静脉内瘘血管瘤的发生率方面的差异性还有待进一步的观察。
参考文献
[1] 张英，韩咏梅，李小萌，等. 持续质量改进对维持性血透患者自
体动静脉内瘘并发症的影响[J]. 护士进修杂志，2013，28（18）：1721-1723.
[2] 陶明芬，王翠珍，许燕，等. 钝针扣眼穿刺技术在自体动静脉内
瘘中的应用[J]. 皖南医学院学报，2016，35（2）：198-199.[3] 姚红. 持续质量改进在减少血液透析永久性导管血栓形成的应用
[J]. 医学理论与实践，2013，26（8）：1086-1087.
[4] 徐珍珍. 钝针扣眼穿刺法在动静脉内瘘中的应用与体会[J]. 医学
信息，2013，26（23）：501．
[5] 邹丽华，杨柳. 三种内瘘穿刺法在血液透析患者中的应用效果比
较[J]. 齐鲁护理杂志，2015，21（14）：20-22．
[6] 沈卫利，沈丹琴. 钝针扣眼穿刺法在自体动静脉内瘘穿刺中的应
用[J]. 当代护士（学术版），2014（3）：126-127.
[7] 余美芳，徐青，张青春. 动静脉内瘘钝针与锐针扣眼法穿刺技术
的临床效果比较[J].解放军护理杂志，2014，31（4）：73-74.[8] 张庆来，张慧，张朝霞. 血液透析专科护士职业认同状况调查研
究[J]. 中国护理管理， 2012，12（1）：61-63.
[9] 周晓娟. 维持性血液透析患者症状群及症状负担与生活质量相关
性研究[D]. 重庆：重庆医科大学，2013：464-467.
在临床治疗中，重症社区获得性肺炎为一种常见的严重肺部
感染疾病[1]，
严重降低了患者的生活质量，威胁了患者的生命健康，蒋永昆 邹小春
亚胺培南西司他丁钠与莫西沙星治疗重症社区获得性肺炎的疗效及经济学对比
作者单位：永州市中心医院南院重症医学科，湖南 永州 425000
【摘要】目的 研究分析亚胺培南西司他丁钠与莫西沙星治疗重症社区获得性肺炎的疗效及经济学对比。方法 选取我院2015年2月—2016年9月收治的100例重症社区获得性肺炎患者为研究对象，随机分为对照组和实验组，每组患者各为50例。对照组患者给予莫西沙星治疗。实验组患者给予亚胺培南西司他丁钠治疗，比较分析实验组与对照组患者的治疗效果指标。结果 经过对应的治疗后，实验组50例患者中，4例患者无效。对照组患者中，13例患者无效。实验组患者的治疗效果（92.0%）高于对照组（74.0%），差异有统计学意义（P ＜0.05）。实验组治疗成本为（6 628.90±823.01）元，对照组患者的治疗成本为（7 378.54±782.07）元。对照组患者治疗成本高于实验组，差异有统计学意义（P ＜0.05）。结论 亚胺培南西司他丁钠与莫西沙星治疗重症社区获得性肺炎相比，亚胺培南西司他丁钠临床效果较好，更加经济。
【关键词】亚胺培南西司他丁钠；莫西沙星；重症社区获得性肺炎；经济学
【中图分类号】R563 【文献标识码】A 【文章编号】1674-9316（2017）18-0074-03doi:10.3969/j.issn.1674-9316.2017.18.036
Efficacy and Economic Comparison of Imipenem and Cilastatin Sodium and Moxifloxacin in the Treatment of Severe Community Acquired Pneumonia
JIANG Yongkun ZOU Xiaochun Department of Critical Care Medicine, South Hospital of Yongzhou Central Hospital, Yongzhou Hu’nan 425000, China
[Abstract] Objective To study and compare the efficacy and economic
comparison of imipenem and cilastatin sodium and moxifloxacin in the
treatment of severe community acquired pneumonia. Methods 100 cases of severe community-acquired pneumonia patients in our hospital from February 2015 to September 2016 were selected as the research object. They were randomly divided into the control group and the experimental group, with 50 patients in each group. The control group received routine treatment and moxifloxacin treatment. The patients in the experimental group were treated with imipenem and cilastatin sodium, and the therapeutic effects of the experimental group and the control group were compared and analyzed. Results After the corresponding treatment, 50 patients in the experimental group, 4 patients were invalid. In the control group, 13 patients were ineffective. The treatment effect of the experimental group (92.0%) was significantly higher than that of the control group (74.0%), the difference was statistically significant (P < 0.05). The cost of treatment in the experimental group was (6628.90 ±823.01) yuan, and the cost of treatment in the control group was (7378.54 ±782.07) yuan. The treatment cost of the control group was higher than that of the experimental group, the difference was statistically significant (P < 0.05). Conclusion Compared with moxifloxacin, the clinical effect of imipenem and cilastatin sodium in the treatment of severe community acquired pneumonia is better, and is more economical and more popularized.
[Keywords] imipenem and cilastatin sodium; moxifloxacin; severe community acquired pneumonia; economics